ZELDA FLEMING: Open Payments
NPI 1376068320 · KERNERSVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 9 payments from 8 companies in 2025. Trend: 2023 $57 · 2024 $952 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Vanda Pharmaceuticals Inc. | 1 | $100 |
| Lilly USA, LLC | 2 | $37 |
| ViiV Healthcare Company | 1 | $35 |
| PFIZER INC. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Abbott Laboratories | 1 | $19 |
| Actelion Pharmaceuticals US, Inc. | 1 | $15 |
Products named: BREZTRI, FANAPT, MOUNJARO, APRETUDE, PREVNAR 20, XIFAXAN, FREESTYLE LIBRE 3, OPSUMIT.
Industry payments across NC — which companies pay providers there.
